Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 83, 152-159
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Target detection: Magnetic resonance imaging-ultrasound fusion–guided prostate biopsyUrologic Oncology: Seminars and Original Investigations, 2014
- Prostate Cancer Aggressiveness: Assessment with Whole-Lesion Histogram Analysis of the Apparent Diffusion CoefficientRadiology, 2014
- Assessment of Prostate Cancer Aggressiveness Using Dynamic Contrast-enhanced Magnetic Resonance Imaging at 3 TEuropean Urology, 2013
- Diffusion‐weighted MRI and its role in prostate cancerNMR in Biomedicine, 2013
- Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor AngiogenesisAmerican Journal of Roentgenology, 2011
- Prostate Cancer Detection in Patients With Total Serum Prostate-Specific Antigen Levels of 4–10 ng/mL: Diagnostic Efficacy of Diffusion-Weighted Imaging, Dynamic Contrast-Enhanced MRI, and T2-Weighted ImagingAmerican Journal of Roentgenology, 2011
- Antivascular Effects of Neoadjuvant Androgen Deprivation for Prostate Cancer: An In Vivo Human Study Using Susceptibility and Relaxivity Dynamic MRIInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Prostate Cancer: Differentiation of Central Gland Cancer from Benign Prostatic Hyperplasia by Using Diffusion-weighted and Dynamic Contrast-enhanced MR ImagingRadiology, 2010
- Trends in Gleason Score: Concordance Between Biopsy and Prostatectomy over 15 YearsUrology, 2008
- Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.Radiology, 1988